Iron poisoning is a leading cause of poisoning deaths in children. Symptoms begin with acute gastroenteritis, followed by a quiescent period, then shock and liver failure. Diagnosis is by measuring serum iron, detecting radiopaque iron tablets in the GI tract, or detecting unexplained metabolic acidosis in patients with other findings suggesting iron poisoning. Treatment of a substantial ingestion is usually whole-bowel irrigation and chelation therapy with IV deferoxamine.
Many commonly used OTC preparations contain iron. Of the many iron compounds used in OTC and prescription preparations, the most common are
To children, iron tablets may look like candy. Prenatal multivitamins are the source of iron in most lethal ingestions among children. Children’s chewable multivitamins with iron usually have such small amounts that toxicity rarely occurs.
Iron is toxic to the GI system, cardiovascular system, and CNS. Specific mechanisms are unclear, but excess free iron is inserted into enzymatic processes and interferes with oxidative phosphorylation, causing metabolic acidosis. Iron also catalyzes free radical formation, acts as an oxidizer, and, when plasma protein binding is saturated, combines with water to form iron hydroxide and free H+ ions, compounding the metabolic acidosis. Coagulopathy may appear early because of interference with the coagulation cascade and later because of liver injury.
Toxicity depends on the amount of elemental iron that has been ingested. Up to 20 mg/kg of elemental iron is not toxic, 20 to 60 mg/kg is mildly to moderately toxic, and > 60 mg/kg can cause severe symptoms and morbidity.
Symptoms of iron poisoning occur in 5 stages (see Table: Stages of Iron Poisoning); however, symptoms and their progression vary significantly. The severity of stage 1 symptoms usually reflects the overall severity of poisoning; late-stage symptoms develop only if stage 1 symptoms are moderate or severe. If no symptoms develop within the first 6 h after ingestion, risk of serious toxicity is minimal. If shock and coma develop within the first 6 h, the mortality rate is about 10%.
Stages of Iron Poisoning
Iron poisoning should be considered in mixed ingestions (because iron is ubiquitous) and in small children with access to iron and unexplained metabolic acidosis or severe or hemorrhagic gastroenteritis. Because children often share, siblings and playmates of small children who have ingested iron should be evaluated.
Abdominal x-ray is usually recommended to confirm ingestion; it detects intact iron tablets or iron concretions but misses chewed and dissolved tablets, liquid iron preparations, and iron in multivitamin preparations. Serum iron, electrolytes, and pH are determined 3 to 4 h after ingestion. Toxicity is assumed if suspected ingestion is accompanied by any of the following:
These iron levels may indicate toxicity; however, iron levels alone do not predict toxicity accurately. Total iron binding capacity is often inaccurate and not helpful in diagnosing serious poisoning and is not recommended. The most accurate approach is to serially measure levels of serum iron, HCO3, and pH (with calculation of the anion gap); these findings are then evaluated together, and results are correlated with the patient’s clinical status. For example, toxicity is suggested by increasing iron levels, metabolic acidosis, worsening symptoms, or, more typically, some combination of these findings.
If radiopaque tablets are visible on abdominal x-ray, whole-bowel irrigation with polyethylene glycol 1 to 2 L/h for adults or 25 to 40 mL/kg/h for children is done until no iron is visible on repeat abdominal x-ray. Administration via NGT may be necessary to deliver these large volumes and care must be taken to protect the airway; intubation may be necessary (see Tracheal Intubation). Gastric lavage is usually not helpful because vomiting tends to empty the stomach more efficiently. Activated charcoal does not adsorb iron and should be used only if other toxins also were ingested.
All patients with more than mild gastroenteritis are hospitalized. Patients with severe toxicity (metabolic acidosis, shock, severe gastroenteritis, or serum iron level > 500 μg/dL) are treated with IV deferoxamine to chelate free serum iron. Deferoxamine is infused at rates up to 15 mg/kg/h IV, titrated until hypotension occurs. Because both deferoxamine and iron poisoning can decrease BP, patients receiving deferoxamine require IV hydration.
Iron toxicity, like some other hepatotoxins, can cause gastroenteritis followed by a quiescent phase, then shock and liver failure.
Suspect iron poisoning in mixed ingestions (because iron is ubiquitous) and in small children with access to iron and unexplained metabolic acidosis or severe or hemorrhagic gastroenteritis.
Suspect that toxicity is severe with increasing iron levels, metabolic acidosis, worsening symptoms, or a combination.
Do whole-bowel irrigation until an abdominal x-ray shows absence of radiopaque iron products.
Give IV deferoxamine to treat severe poisoning (eg, metabolic acidosis, shock, severe gastroenteritis, serum iron level > 500 μg/dL).
Drug NameSelect Trade